Bio-Rad Laboratories
(BIO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2008 | 12-2007 | 09-2007 | 06-2007 | 03-2007 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 129,480 | 161,764 | 472,792 | 232,403 | 230,314 |
| Marketable Securities | 47,643 | 61,977 | 70,613 | 270,463 | 241,418 |
| Receivables | 366,509 | 358,076 | 303,201 | 303,266 | 290,116 |
| Inventories | 365,059 | 321,015 | 273,575 | 265,185 | 259,965 |
| Income taxes - deferred | N/A | 36,450 | N/A | N/A | N/A |
| TOTAL | $1,049,031 | $1,028,974 | $1,219,562 | $1,167,739 | $1,129,692 |
| Non-Current Assets | |||||
| PPE Net | 287,573 | 271,561 | 201,608 | 191,605 | 188,763 |
| Intangibles | 585,285 | 538,743 | 164,027 | 165,764 | 163,712 |
| Other Non-Current Assets | 131,399 | 132,316 | 127,287 | 129,635 | 124,876 |
| TOTAL | $1,004,257 | $942,620 | $492,922 | $487,004 | $477,351 |
| Total Assets | $2,053,288 | $1,971,594 | $1,712,484 | $1,654,743 | $1,607,043 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | 10,997 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 98,929 | 96,470 | 68,102 | 67,229 | 61,946 |
| Accrued Expenses | 96,836 | 121,255 | 89,769 | 82,436 | 70,590 |
| Other current liabilities | 98,567 | 106,708 | 72,299 | 72,485 | 68,158 |
| TOTAL | $387,446 | $414,168 | $286,461 | $281,849 | $272,091 |
| Non-Current Liabilities | |||||
| Long Term Debt | 442,446 | 441,805 | 426,141 | 426,165 | 425,504 |
| Other Non-Current Liabilities | 90,292 | 92,716 | 41,493 | 38,592 | 36,577 |
| TOTAL | $583,575 | $585,736 | $479,683 | $476,095 | $474,288 |
| Total Liabilities | $971,021 | $999,904 | $766,144 | $757,944 | $746,379 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 27,010 | 26,968 | 26,845 | 26,701 | 26,650 |
| Common Shares | 3 | 3 | 3 | 3 | 3 |
| Retained earnings | 788,562 | 762,067 | 749,712 | 721,741 | 696,070 |
| Other shareholders' equity | 187,706 | 110,991 | 102,537 | 85,765 | 78,964 |
| TOTAL | $1,082,267 | $971,690 | $946,340 | $896,799 | $860,664 |
| Total Liabilities And Equity | $2,053,288 | $1,971,594 | $1,712,484 | $1,654,743 | $1,607,043 |